Skip to main content
Caplight Logo









Laronix

Laronix

Private
BrisbaneHealthcare & Life Scienceshttps://www.laronix.com/

Last Round

Grant

Nov 12, 2025

Total Funding Raised

$577,000

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Laronix is a medical technology company that develops non-invasive, AI-powered voice restoration devices for individuals suffering from permanent or acute voice loss.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Health IoT, NLP & Conversational AI

Business Model

B2B

Customer Profile

Hardware Sales, Subscription SaaS

AI Layer

Application

Keywords

artificial larynxvoice restorationlaryngectomywearable medical devicespeech synthesisassistive technologyelectrolarynxvoice prosthesisbionic voicespeech-language pathologyotolaryngologymedtechhealth iotai voicevocal cord replacement

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Laronix Comparables

Compare Laronix with similar companies based on industry and business-model similarity.

Laronix comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Altavo
85%
Labex Trade Ltd.
83%
UltraVoice, Ltd.
79%

Laronix Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantNov 12, 2025
VC RoundAug 31, 2023
GrantAug 25, 2021
SeedSep 1, 2020

Key People

Founding team and executive leadership

Mousa Ahmadi

Chief Operating Officer Co-Founder

Founding Team

Laronix Investors

Notable investors and investment history

Laronix investors
InvestorRounds
Scale InvestorsSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 23, 2026

    Grew 19% QoQ, from 16 to 19 employees.

  • Apr 20, 2026

    Monthly visitors increased 31% MoM, reaching 1.7K.

Recent news

Latest coverage and updates

  • receives_financingJul 27, 2026

    Laronix Inc. received financing of $2M in Seed on Aug 1st '23.

  • is_developingJul 27, 2026

    Laronix Inc. is developing ways to help people speak again after they've had larynx removed. on Jul 1st '20.

Laronix Filings

Explore SEC and related filing metadata, where available.

Laronix filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Laronix's valuation, stock price, and market status.

Is Laronix a public or private company?

Laronix is a private company.

What is the current stock price of Laronix?

Laronix is a private company with no public stock price. No recent secondary market data is available.

How much is Laronix worth (valuation)?

Valuation information for Laronix is not publicly available.

Can I buy Laronix stock?

Laronix shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Laronix's last funding round?

Laronix's most recent funding round was Grant on November 12, 2025.

Who are the main investors in Laronix?

Key investors in Laronix include Scale Investors.

Will Laronix IPO soon?

No public IPO plans have been announced for Laronix.

How can I track Laronix secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Laronix's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersBrisbane
Employee Range14
Year Founded2018
Last FundingNov 12, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?